Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Journal of Bacteriology
|
August 1, 1983
Cloning and expression in Escherichia coli and Bacillus subtilis of the hemolysin (cereolysin) determinant from Bacillus cereus
J Kreft, H Berger, M Härtlein, et al.
The American Journal of Cardiology
|
July 13, 1995
Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease
H W Eichstädt, H Eskötter, I Hoffman, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|
April 1, 1987
E. coli maltodextrin phosphorylase: primary structure and deletion mapping of the C-terminal site
D Palm, R Goerl, G Weidinger, et al.
Cardiovascular Drugs and Therapy
|
March 11, 1998
Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension
D B Pittrow, A Antlsperger, D Welzel, et al.
Microbes and Infection
|
January 4, 2001
Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis
S Spreng, I Gentschev, W Goebel, et al.
Atherosclerosis
|
June 25, 1999
A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease
G Rothe, A S Herr, J Stöhr, et al.
Blood Pressure
|
November 14, 1997
Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor
R Griebenow, D B Pittrow, G Weidinger, et al.
Blood Pressure. Supplement
|
January 1, 1994
Pharmacokinetics of spirapril and spiraprilat in patients with chronic renal failure
G Stein, B Sierakowski, P Grass, et al.
Thrombosis Research
|
October 9, 1999
Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor
G Huhle, C Abletshauser, N Mayer, et al.
Mycoses
|
October 28, 1999
Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial
R Schopf, O Hettler, M Bräutigam, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Journal of Bacteriology
|
August 1, 1983
Cloning and expression in Escherichia coli and Bacillus subtilis of the hemolysin (cereolysin) determinant from Bacillus cereus
J Kreft, H Berger, M Härtlein, et al.
The American Journal of Cardiology
|
July 13, 1995
Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease
H W Eichstädt, H Eskötter, I Hoffman, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|
April 1, 1987
E. coli maltodextrin phosphorylase: primary structure and deletion mapping of the C-terminal site
D Palm, R Goerl, G Weidinger, et al.
Cardiovascular Drugs and Therapy
|
March 11, 1998
Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension
D B Pittrow, A Antlsperger, D Welzel, et al.
Microbes and Infection
|
January 4, 2001
Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis
S Spreng, I Gentschev, W Goebel, et al.
Atherosclerosis
|
June 25, 1999
A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease
G Rothe, A S Herr, J Stöhr, et al.
Blood Pressure
|
November 14, 1997
Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor
R Griebenow, D B Pittrow, G Weidinger, et al.
Blood Pressure. Supplement
|
January 1, 1994
Pharmacokinetics of spirapril and spiraprilat in patients with chronic renal failure
G Stein, B Sierakowski, P Grass, et al.
Thrombosis Research
|
October 9, 1999
Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor
G Huhle, C Abletshauser, N Mayer, et al.
Mycoses
|
October 28, 1999
Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial
R Schopf, O Hettler, M Bräutigam, et al.
Page
of 9